Bitolterol

RESPIRATORY SYSTEM

Key facts

Bitolterol is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1984. DrugCentral lists 1 molecular target, including ADRB2. Recorded indications include Acute exacerbation of asthma, Asthma, Asthma management and Bronchiectasis.

• Approval status: ofm (first approved 1984 by the FDA).
• Molecular targets: ADRB2 (1 listed in DrugCentral).
• Indications: Acute exacerbation of asthma, Asthma, Asthma management, Bronchiectasis and Bronchitis and others.
• ATC code: R03AC17 (Selective beta-2-adrenoreceptor agonists).
• Molecular formula: C28H31NO5; molecular weight 461.56 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (7)

• Acute exacerbation of asthma
• Asthma
• Asthma management
• Bronchiectasis
• Bronchitis
• Bronchospasm Prevention
• Pulmonary emphysema

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Beta-2 adrenergic receptor	ADRB2	agonist	—

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1984-12-28	FDA	—	SANOFI AVENTIS US

ATC classification

ATC code	Therapeutic hierarchy
R03AC17	RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › ADRENERGICS, INHALANTS › Selective beta-2-adrenoreceptor agonists

Chemical structure

• Molecular formula: C₂₈H₃₁NO₅
• Molecular weight: 461.56 g/mol
• CAS number: —
• InChIKey: FZGVEKPRDOIXJY-UHFFFAOYSA-N
• PubChem CID: 35330

CC1=CC=C(C=C1)C(=O)OC1=C(OC(=O)C2=CC=C(C)C=C2)C=C(C=C1)C(O)CNC(C)(C)C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Bitolterol used for?

DrugCentral lists the following indications for Bitolterol: Acute exacerbation of asthma, Asthma, Asthma management, Bronchiectasis, Bronchitis, Bronchospasm Prevention and Pulmonary emphysema.

How does Bitolterol work?

Its molecular targets in DrugCentral include ADRB2 (agonist).

When was Bitolterol first approved?

Bitolterol was first approved by the FDA in 1984.

What is the chemical formula of Bitolterol?

Bitolterol has the molecular formula C28H31NO5 and a molecular weight of 461.56 g/mol.

Sources

• DrugCentral drug card 384 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1200405 — compound record and bioactivity
• PubChem CID 35330 — chemical identifiers
• DrugBank DB00901 — drug record
• FDA UNII 9KY0QXD6LI — substance identity
• DailyMed: FDA labels for Bitolterol — current prescribing information (label search)
• UniProt P07550 (ADRB2) — target protein

How this page is built: methodology · editorial policy & corrections.